Abdul Basit
@ProfAWBasit
Professor of Pharmaceutics at @UCL @BasitResearch | Founder and Director at @IntractPharma and @FabRx_3DP | All views are my own
ID:724916965874257920
https://iris.ucl.ac.uk/iris/browse/profile?upi=ABASI56 26-04-2016 11:04:07
440 Tweet
635 Takipçi
303 Takip Edilen
Only 1 week to go! Register for our Pharma3DPI Introductions Webinar now!
url.uk.m.mimecastprotect.com/s/orDXCAQvJijy…
Atheer Awad Alvaro Goyanes Eneko Larraneta
We are at Clinical Pharmacy Congress! Come and find us at stand K53 and learn more about pharmaceutical 3D printing for personalised medicine!
#FABRX #3DPrintung #CPCCongress #CPC2024 #CPC24
Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders dlvr.it/T69YCB #excipients #pharmaceutical #formulation
A new paper from Germany has just dropped using FABRX's M3DIMAKER and our DPE printhead! Tablets printed with drug control, ASDs formed from loperamide in Polyvinylalcohol, and release patterns modulated via infill adjustments & sorbitol!
📖: fabrx.co.uk/2024/4/25/new-…
#M3DIMAKER
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib.
| Abdul W. Basit UCL School of Pharmacy | UKICRS Abdul Basit
[50 days' free access]
#OralDelivery #ExtendedRelease
authors.elsevier.com/sd/article/S01…
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib.
| Abdul W. Basit UCL School of Pharmacy | Abdul Basit UKICRS
#ColonicTargeting #ExtendedRelease #upadacitinib
doi.org/10.1016/j.jcon…
Our latest batch of FABRX pharmaceutical 3D printers is en-route to the US! These printers are revolutionising drug delivery and personalised medicine worldwide! 🌎💊
#FABRX #Pharma #Innovation #3DPrinting
#Paper 'Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders.' Lucía Rodríguez-Pombo, Carmen Alvarez-Lorenzo, Abdul Basit, Alvaro Goyanes, et al. iMATUS (Instituto de Materiales de la USC), Instituto de Invest. Sanitaria de Santiago (IDIS) USC, University College London. sciencedirect.com/science/articl…
Visitamos a investigadores de la ULL que trabajan en un proyecto para la impresión de medicamentos con tecnología 3D
Podría suponer una revolución para pacientes que necesitan un tratamiento especializado
#TN2Canarias
Such a great day yesterday at the SoP Research Day! I won the best lecture (runner-up) award presenting my project on the interactions between the gut microbiota and drugs. Thanks to my supervisors Mine Orlu, Abdul Basit, the talented Basit Research Group and COLOTAN - ITN ! 🏆🌟🎯 #UCL
The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome.
| Abdul W. Basit UCL School of Pharmacy | UKICRS Abdul Basit
[50 days' free access]
#ColonTargeting #EntericFilmCoating #microbiome
authors.elsevier.com/sd/article/S01…
Researcher spotlight! 🔦
Discover how this new research article explores the transformative potential of 3D printing in pharmaceuticals with FABRX’s M3DIMAKER, ensuring quality and precision in dosage forms!
Read more:
fabrx.co.uk/2024/3/21/brea…
#M3DIMAKER #FABRX #3DPrinting
Poly(D,l-lactide-co-glycolide) particles are metabolised by the gut microbiome and elevate short chain fatty acids dlvr.it/T5LvSH #excipients #pharmaceutical #formulation
#paper 'Customizable orodispersible films: Inkjet printing and data matrix encoding for personalized hydrocortisone dosing'. Lucía Rodríguez-Pombo Alvaro Goyanes Carmen Alvarez-Lorenzo Abdul Basit FABRX iMATUS (Instituto de Materiales de la USC) et al. sciencedirect.com/science/articl…
Our latest study pioneers inkjet printing for customisable drug-loaded orodispersible films, embedding vital info in data matrices generated by M3DIMAKER Studio™ software.
Learn more about this research here: fabrx.co.uk/2024/4/10/adva…🔬
#FABRX #PersonalisedMedicine #DrugDelivery
Poly(D,l-lactide-co-glycolide) particles are metabolised by the gut microbiome and elevate short chain fatty acids.
| Abdul W. Basit UCL School of Pharmacy | Abdul Basit UKICRS
[50 days' free access]
#PLGA #FattyAcid #microbiome
authors.elsevier.com/sd/article/S01…